LXP faces merger-related shareholder suit and 14 demand letters; voluntarily supplements proxy

LXP Industrial Trust

LXP faces one shareholder complaint, Garfield v. Eglin (N.Y. Sup. Ct. filed Oct. 9, 2026), seeking to enjoin the Oct. 26, 2026 special meeting vote and the merger closing.
LXP received 14 demand letters from law firms alleging disclosure deficiencies in its preliminary and definitive proxy statements; the company denies the claims as without merit.
LXP supplemented its Sept. 18, 2026 proxy with BofA analyses: selected deals at 15.8x-21.5x NTM EBITDA and a DCF using 8.1%-9.2% discount rates.
Brookfield/CPPIB's June 6, 2026 revised non-binding proposal offered $60.00 per LXP common share, up from earlier bids of $50.00, $55.00, $56.00 and $57.25.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.